ConductScience.org, home

Paper41449752

The importance of assessing the fitness of older patients with newly diagnosed diffuse large B-cell lymphoma and classic Hodgkin lymphoma.

Zilioli VR and 5 others. Br J Haematol, 2026. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. The importance of assessing the fitness of older patients with newly diagnosed diffuse large B-cell lymphoma and classic Hodgkin lymphoma. Papers, record 41449752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41449752

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The importance of assessing the fitness of older patients with newly diagnosed diffuse large B-cell lymphoma and classic Hodgkin lymphoma.
PubMed
Journal
Br J Haematol
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2026-01-23
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zilioli VRVittorio Ruggero
2Tucci AAlessandra
3Spina MMichele
4Merli FFrancescohttps://orcid.org/0000-0002-0979-7883
5Arcari AAnnalisa
6Elderly Lymphoma Committee of the Fondazione Italiana LinfomiGroup

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Lymphoma, Large B-Cell, DiffuseMajor topic
Hodgkin DiseaseMajor topic
Geriatric AssessmentMajor topic
Humans
Aged
Prognosis
Aged, 80 and over
Frailty
Female
Male

Source PubMed

Download CSV of topics

References54

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122117038A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern era.Blood2012https://conductscience.org/library/papers/22117038PubMed
234041751Association of the Geriatric 8 with treatment intensity and prognosis in older patients with diffuse large B-cell lymphoma.Br J Haematol2021https://conductscience.org/library/papers/34041751PubMed
320392703Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.Age Ageing2010https://conductscience.org/library/papers/20392703PubMed
434448831Multicenter analysis of geriatric fitness and real-world outcomes in older patients with classical Hodgkin lymphoma.Blood Adv2021https://conductscience.org/library/papers/34448831PubMed
534162178Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 study.Haematologica2022https://conductscience.org/library/papers/34162178PubMed
619562776A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy.Cancer2009https://conductscience.org/library/papers/19562776PubMed
739316716The current landscape of frontline large B-cell lymphoma trials.Blood2025https://conductscience.org/library/papers/39316716PubMed
823509323How can outcomes be improved for older patients with Hodgkin lymphoma?J Clin Oncol2013https://conductscience.org/library/papers/23509323PubMed
912406082Hodgkin's disease in the elderly: a population-based study.Br J Haematol2002https://conductscience.org/library/papers/12406082PubMed
1025110825
Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation (FIL).
Leuk Lymphoma2015https://conductscience.org/library/papers/25110825PubMed
1133577377Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi.J Clin Oncol2021https://conductscience.org/library/papers/33577377PubMed
1231228094Considerations for the Treatment of Diffuse Large B Cell Lymphoma in the Elderly.Curr Hematol Malig Rep2019https://conductscience.org/library/papers/31228094PubMed
1327104110Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.J Cachexia Sarcopenia Muscle2016https://conductscience.org/library/papers/27104110PubMed
1436495588The Advanced-Stage Hodgkin Lymphoma International Prognostic Index: Development and Validation of a Clinical Prediction Model From the HoLISTIC Consortium.J Clin Oncol2023https://conductscience.org/library/papers/36495588PubMed
1517488980Comprehensive geriatric assessment for older patients with cancer.J Clin Oncol2007https://conductscience.org/library/papers/17488980PubMed
1636098030Frailty assessment in the care of older people with haematological malignancies.Lancet Healthy Longev2021https://conductscience.org/library/papers/36098030PubMed
1740357855Comparative Effectiveness of R-miniCOMP Versus R-miniCHOP in Older Non-Fit Patients With Diffuse Large B-Cell Lymphoma: Insights From a "Fondazione Italiana Linfomi" Cohort Study.Hematol Oncol2025https://conductscience.org/library/papers/40357855PubMed
1823781925Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy.Leuk Lymphoma2014https://conductscience.org/library/papers/23781925PubMed
1928524259
Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi.
Hematol Oncol2018https://conductscience.org/library/papers/28524259PubMed
2021482186Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial.Lancet Oncol2011https://conductscience.org/library/papers/21482186PubMed

See all 54 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42694221Age and CIRS-G for risk stratification in elderly esophageal squamous cell carcinoma patients receiving definitive chemoradiotherapy.Front Oncol2026https://conductscience.org/library/papers/42694221PubMed
42460098Classical Hodgkin Lymphoma Today.Mediterr J Hematol Infect Dis2026https://conductscience.org/library/papers/42460098PubMed
41449752The importance of assessing the fitness of older patients with newly diagnosed diffuse large B-cell lymphoma and classic Hodgkin lymphoma.Br J Haematol2026https://conductscience.org/library/papers/41449752PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41449752

GET https://conductscience.org/api/papers/v1/41449752/references?page=2